DNA-protein biomarkers for immunotherapy in the era of precision oncology
The use of biomarkers to guide patient and therapy selection has gained much attention to increase the scope and complexity of targeted therapy options and immunotherapy. Clinical trials provide a basis for discovery of biomarkers, which can then aid in development of new drugs. To that end, samples...
Saved in:
Main Authors: | Binnari Kim (Author), So Young Kang (Author), Kyoung-Mee Kim (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploiting DNA Damage Response in the Era of Precision Oncology
Published: (2020) -
Precision Oncology and Cancer Biomarkers Issues at Stake and Matters of Concern
Published: (2022) -
Precision Oncology and Cancer Biomarkers Issues at Stake and Matters of Concern /
Published: (2022) -
Precision Oncology and Cancer Biomarkers Issues at Stake and Matters of Concern
Published: (2022) -
Is there room for allergen immunotherapy for the treatment of atopic dermatitis in the precision medicine era?
by: Benedetta Pessina, et al.
Published: (2022)